Category Research

Charles River and Toxys Partner to Advance NAMs for Developmental Toxicity Testing

Charles River and Toxys Partner to Advance NAMs for Developmental Toxicity Testing

Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…

Read MoreCharles River and Toxys Partner to Advance NAMs for Developmental Toxicity Testing
Kernal Bio Wins Up to $48M from ARPA-H to Develop Affordable In Vivo CAR T Therapies

Kernal Bio Wins Up to $48M from ARPA-H to Develop Affordable In Vivo CAR T Therapies

Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…

Read MoreKernal Bio Wins Up to $48M from ARPA-H to Develop Affordable In Vivo CAR T Therapies
Hesperos and Bayer Develop First Human-on-a-Chip® Model

Hesperos and Bayer Develop First Human-on-a-Chip® Model for Stress-Related Cognitive Dysfunction

Hesperos, Inc., a global leader in developing Human-on-a-Chip® (HoaC) technology for improving preclinical testing across pharmaceuticals, food, cosmetics, and chemicals, has announced a groundbreaking advancement in neuroscience research. In collaboration with Bayer Consumer Health, the company has unveiled the first…

Read MoreHesperos and Bayer Develop First Human-on-a-Chip® Model for Stress-Related Cognitive Dysfunction
Seek Labs Advances Pan-Orthopoxvirus Drug Development

Seek Labs Advances Pan-Orthopoxvirus Drug Development with BioSeeker™ and PTAP™

Seek Labs, a biotechnology company at the forefront of AI-driven drug discovery and programmable therapeutics, has announced major progress in the development of what could become the world’s first pan-orthopoxvirus therapeutic. This next-generation treatment aims to provide broad protection against…

Read MoreSeek Labs Advances Pan-Orthopoxvirus Drug Development with BioSeeker™ and PTAP™
Alpenglow Biosciences and Virdx Partner to Advance AI Prostate Cancer Diagnostics

Alpenglow Biosciences and Virdx Partner to Advance AI Prostate Cancer Diagnostics

Alpenglow Biosciences, a pioneer in AI-powered 3D pathology, has announced a strategic multi-year partnership with Virdx, a biophysics AI company specializing in MRI-based cancer detection. The collaboration aims to accelerate the development of next-generation diagnostic tools, combining the strengths of…

Read MoreAlpenglow Biosciences and Virdx Partner to Advance AI Prostate Cancer Diagnostics
https://www.businesswire.com/news/home/20251007878567/en/MathWorks-Launches-Generative-AI-powered-MATLAB-Copilot-to-Boost-Productivity-and-Accelerate-Development-for-Engineers-Scientists-and-Researchers

MathWorks Unveils AI-Powered MATLAB Copilot to Accelerate Engineering and Research

MathWorks has announced the launch of MATLAB Copilot, a generative AI–powered assistant designed to boost productivity and accelerate development for engineers, scientists, and researchers. Integrated directly into the MATLAB and Simulink Release 2025b (R2025b), MATLAB Copilot brings the power of…

Read MoreMathWorks Unveils AI-Powered MATLAB Copilot to Accelerate Engineering and Research
bioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test

bioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test

bioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, announced record sales growth for its flagship diagnostic test, CyPath®…

Read MorebioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test